Evidence map›Paper›PMID 36800196›Full record

ArticleJAMA health forum2023

Antibiotic Receipt During Outpatient Visits for COVID-19 in the US, From 2020 to 2022.

Samuel R Wittman, Judith M Martin, Ateev Mehrotra, Kristin N Ray

Open access · goldAbstract read
In one paragraph

Article in JAMA health forum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the COVID-19 Outbreak: An Interrupted Time Series Analysis of 2016-2021 Data.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  3. Article
  4. Article
  5. Update on outpatient antibiotic prescribing during the COVID-19 pandemic: United States, 2020-2022.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Samuel R WittmanDepartment of Pediatrics, University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
Judith M MartinDepartment of Pediatrics, University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
Ateev MehrotraDepartment of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
Kristin N RayDepartment of Pediatrics, University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
Children's Hospital of Pittsburgh · USHarvard University · USUniversity of Pittsburgh Medical Center · US

Funding

Understanding Use of Direct to Consumer Telemedicine for Pediatric Acute Respiratory InfectionsR01AI148159 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI RAY, KRISTIN N · 2020 to 2023
$2.9M
NIAID NIH HHS R01 AI148159
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Respiratory Tract InfectionsAnti-Bacterial AgentsDrug PrescriptionsHumansOutpatientsAnti-Bacterial Agents

Identifiers

PMID36800196
PMCPMC9938423
OpenAlexW4321167023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.